341 related articles for article (PubMed ID: 24269836)
1. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases.
Dekker FJ; van den Bosch T; Martin NI
Drug Discov Today; 2014 May; 19(5):654-60. PubMed ID: 24269836
[TBL] [Abstract][Full Text] [Related]
2. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of histone deacetylases (HDACs) in UPR regulation.
Kahali S; Sarcar B; Chinnaiyan P
Methods Enzymol; 2011; 490():159-74. PubMed ID: 21266250
[TBL] [Abstract][Full Text] [Related]
4. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
Spange S; Wagner T; Heinzel T; Krämer OH
Int J Biochem Cell Biol; 2009 Jan; 41(1):185-98. PubMed ID: 18804549
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
[TBL] [Abstract][Full Text] [Related]
7. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
8. [Histone deacetylase inhibitors as therapeutic agents for polyglutamine disorders].
Jiang H; Jia D; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):52-5. PubMed ID: 20140868
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation.
Leus NG; Zwinderman MR; Dekker FJ
Curr Opin Chem Biol; 2016 Aug; 33():160-8. PubMed ID: 27371876
[TBL] [Abstract][Full Text] [Related]
10. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
[TBL] [Abstract][Full Text] [Related]
11. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
Ganai SA; Banday S; Farooq Z; Altaf M
Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.
Cantley MD; Haynes DR
Inflammopharmacology; 2013 Aug; 21(4):301-7. PubMed ID: 23341163
[TBL] [Abstract][Full Text] [Related]
13. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code.
Calao M; Burny A; Quivy V; Dekoninck A; Van Lint C
Trends Biochem Sci; 2008 Jul; 33(7):339-49. PubMed ID: 18585916
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy.
Stratton MS; McKinsey TA
Biochem Cell Biol; 2015 Apr; 93(2):149-57. PubMed ID: 25707943
[TBL] [Abstract][Full Text] [Related]
15. The HAT/HDAC interplay: multilevel control of STAT signaling.
Icardi L; De Bosscher K; Tavernier J
Cytokine Growth Factor Rev; 2012 Dec; 23(6):283-91. PubMed ID: 22989617
[TBL] [Abstract][Full Text] [Related]
16. The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases.
van den Bosch T; Boichenko A; Leus NGJ; Ourailidou ME; Wapenaar H; Rotili D; Mai A; Imhof A; Bischoff R; Haisma HJ; Dekker FJ
Biochem Pharmacol; 2016 Feb; 102():130-140. PubMed ID: 26718586
[TBL] [Abstract][Full Text] [Related]
17. Impact of protein acetylation in inflammatory lung diseases.
Ito K; Charron CE; Adcock IM
Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252
[TBL] [Abstract][Full Text] [Related]
18. Role of histone acetyltransferases and histone deacetylases in adipocyte differentiation and adipogenesis.
Zhou Y; Peng J; Jiang S
Eur J Cell Biol; 2014 Apr; 93(4):170-7. PubMed ID: 24810880
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases.
Edwards AJ; Pender SL
Biochem Soc Trans; 2011 Aug; 39(4):1092-5. PubMed ID: 21787354
[TBL] [Abstract][Full Text] [Related]
20. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]